Template:Stroke DDX: Difference between revisions

No edit summary
Line 11: Line 11:
*[[Labyrinthitis]]
*[[Labyrinthitis]]
*[[Drug toxicity]]
*[[Drug toxicity]]
**Lithium, phenytoin, carbamazepine
**[[Lithium toxicity|Lithium]], [[phenytoin toxicity|phenytoin]], [[carbamazepine toxicity|carbamazepine]]
*[[Bell's Palsy]]
*[[Bell's Palsy]]
*Complicated [[migraine]]
*Complicated [[migraine]]
*[[Meniere Disease]]
*[[Meniere Disease]]
*Demyelinating disease ([[MS]])
*Demyelinating disease ([[MS]])
*Conversion disorder
*[[Conversion disorder]]
*[[Transient global amnesia]]
*[[Transient global amnesia]]
*[[Giant cell arteritis]]
*[[Giant cell arteritis]]
*[[Cerebral venous sinus thrombosis]]
*[[Cerebral venous sinus thrombosis]]

Revision as of 15:08, 31 August 2019